Regulatory Toxicology and Pharmacology

Papers
(The H4-Index of Regulatory Toxicology and Pharmacology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Target organ toxicity in Sprague Dawley rats following oral exposure to complex groundwater mixture: Assessment of dose-response relationships using histopathological and biochemical alterations122
A review of common approaches to determining allocation factors and relative source contribution factors for drinking water contaminants: caveats and areas for improvement83
Two-year carcinogenicity study of a novel plasticizer, bis(2-ethylhexyl) cyclohexane-1,4-dicarboxylate (Eco-DEHCH), by oral diet in Han Wistar rats81
Selectively addressing total risk avoidance for certain chemicals while overlooking others: The case of per-and-poly-fluoroalkyls75
Prevalence and sample sizes in pre-clinical studies75
Preclinical safety evaluation of the ethanolic extract from the aerial parts of Gomphrena celosioides Mart. in rodents68
Controlling cleaning agent residues in pharmaceutical manufacturing: A harmonized scientific strategy67
Is periventricular heterotopia a useful endpoint for developmental thyroid hormone system disruption in mouse toxicity studies?57
Safety evaluation of ondansetron after gestational exposure on male reproductive parameters in rats57
Ames mutagenicity of 15 aryl, benzyl, and aliphatic ring N-nitrosamines52
Risk Assessment and Pharmacokinetic Modeling of Incidental Ingestion of Ethanol from Mouthwash51
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs)49
A Cautionary tale for using read-across for cancer hazard classification: Case study of isoeugenol and methyl eugenol47
Control of N-nitrosamine impurities in drug products: Progressing the current CPCA framework and supporting the derivation of robust compound specific acceptable intakes42
HESI GTTC ring trial: Concordance between Ames and rodent carcinogenicity outcomes for N-nitrosamines (NAs) with rat and hamster metabolic conditions41
Incorporating Singaporean habits and practices for cosmetics and personal care products into a global consumer aggregate exposure model39
Decision making in next generation risk assessment for skin allergy: Using historical clinical experience to benchmark risk38
Acute dose toxicity evaluation of the food supplement calcium 3-hydroxy-3-methylbutyrate (HMB) in female Sprague Dawley rats37
Importance of tailored non-clinical safety testing of novel antimalarial drugs: Industry best-practice36
Toltrazuril sulfone (Ponazuril) residue depletion in pig tissues and estimated withdrawal intervals35
Apparent Khat chewers exposure to DDT in Ethiopia and its potential toxic effects: A scoping review34
Editorial: 2024 - A promising start for regulatory toxicology and pharmacology34
Editorial Board33
Editorial Board32
Results from two-year rodent oral carcinogenicity studies of cizolirtine, a substance-P and calcitonin gene-related peptide release modulator32
False positive findings associated with adenoviral vector-based vaccine underscore the regulatory necessity to eliminate abnormal toxicity test32
Scientific considerations in the regulatory approval of generic (or biosimilar) version of enoxaparin sodium – A lifesaving carbohydrate polymer32
Expert panel evaluation of the tumor modes of action for 1,4-dioxane and their implications for human risk assessment30
Exploring the potential of ToxCastâ„¢ data for mechanism-based prioritization of chemicals in regulatory context: Case study with priority existing chemicals (PECs) under K-REACH30
Editorial Board30
0.098926782608032